Emergent BioSolutions to reduce workforce
Emergent will reduce its current workforce by about 300 employees “across all areas of the company” and will eliminate about 85 job openings, the company said Wednesday
Simultaneously, the company will close its Baltimore-Bayview drug substance manufacturing facility and its Rockville drug product facility, both of which are located in Maryland. The firm’s sites in Winnipeg, Canada, and Lansing, Michigan, will conduct the bulk of operations going forward, while the company “actively explores strategic alternatives for its other sites throughout the year.”
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins